Use of evidence-based pharmacotherapy after myocardial infarction in Estonia

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Marandi, Toomas ^a   Baburin, Aleksei ^b,c   Ainla, Tiia ^a,d  

^a North Estonia Medical Centre   (Estonia)

^b NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^c UNIVERSITY OF TAMPERE   (Finland)

^d UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; DRUG UTILIZATION; ESTONIA; EVIDENCE BASED MEDICINE; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG UTILIZATION; ESTONIA; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 77953718399     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-358     Document Type: Article

References (21)

1. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. ME Bertrand ML Simoons KA Fox KA Fox LC Wallentin CW Hamm E McFadden PJ De Feyter G Specchia W Ruzyllo, Eur Heart J 2002 23 23 1809 1840 10.1053/euhj.2002.3385 12503543
2. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. F Van de Werf D Ardissino A Betriu DV Cokkinos E Falk KAA Fox D Julian M Lengyel FJ Neumann W Ruzyllo C Thygesen SR Underwood A Vahanian FWA Verheugt W Wijns, Eur Heart J 2003 24 1 28 66 10.1016/S0195-668X(02)00618-8 12559937
3. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. F Van de Werf J Bax A Betriu C Blomstrom-Lundqvist F Crea V Falk G Filippatos K Fox K Huber A Kastrati A Rosengren PG Steg M Tubaro F Verheugt F Weidinger M Weis, Eur Heart J 2008 29 2909 2945 10.1093/eurheartj/ehn526 19004841
4. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. JP Bassand CW Hamm D Ardissino E Boersma A Budaj F Fernndez-Avilés KAA Fox D Hasdai M Ohman L Wallentin W Wijns, Eur Heart J 2007 28 1598 1660 10.1093/eurheartj/ehm132 17569677
5. Diagnosis and treatment of acute myocardial infarction in tertiary and secondary care hospitals in Estonia. T Ainla T Marandi R Teesalu A Baburin M Elmet A Liiver M Peeba J Voitk, Scand J Public Health 2006 34 3 327 331 10.1080/14034940500242019 16754592
6. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. GH Gislason JN Rasmussen SZ Abildstrøm N Gadsbøll P Buch J Friberg S Rasmussen L Køber S Stender M Madsen C Torp-Pedersen, Eur Heart J 2006 27 1153 1158 10.1093/eurheartj/ehi705 16399775
7. Patient adherence: The next frontier in Quality Improvement. PA Heidenreich, Am J Med 2004 117 130 132 10.1016/j.amjmed.2004.03.007 15234651
8. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/
9. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. E Simpson C Beck H Richard MJ Eisenberg L Pilote, Am Heart J 2003 145 3 438 444 10.1067/mhj.2003.143 12660666
10. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. JM Kramer B Hammill KJ Anstrom D Fetterolf R Snyder JP Charde BS Hoffman N Allen LaPointe E Peterson, Am Heart J 2006 152 3 454.e1 8 10.1016/j.ahj.2006.02.030 (Pubitemid 44233428)
11. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. KA Eagle E Kline-Rogers SG Goodman EP Gurfinkel A Avezum MD Flather CB Granger S Erickson K White PG Steg, Am J Med 2004 15, 117 2 73 81 10.1016/j.amjmed.2003.12.041 (Pubitemid 38953725)
12. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. HY Lee CE Cooke TA Robertson, J Manag Care Pharm 2008 14 3 271 280 18439049
13. External validity of randomised controlled trials: "To whom do the results of this trial apply?". PM Rothwell, Lancet 2005 365 82 93 10.1016/S0140-6736(04)17670-8 15639683
14. Comparison of management and 30-day mortality of acute myocardial infarction in men versus women in Estonia. T Bakler A Baburin R Teesalu M Rahu, Acta Cardiol 2004 59 275 281 10.2143/AC.59.3.2005182 15255459
15. Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. F Schiele N Meneveau MF Seronde F Caulfield R Fouche G Lassabe D Baborier P Legalery JP Bassand, Eur Heart J 2005 26 9 873 880 10.1093/eurheartj/ehi107 15681575
16. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. L Mandelzweig A Battler V Boyko H Bueno N Danchin G Filippatos A Gitt D Hasdai Y Hasin J Marrugat F Van de Werf L Wallentin S Behar Euro Heart Survey Investigators, Eur Heart J 2006 27 19 2285 2293 10.1093/eurheartj/ehl196 16908490
17. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. A Rosengren L Wallentin M Simoons AK Gitt S Behar A Battler D Hasdai, Eur Heart J 2006 27 7 789 795 10.1093/eurheartj/ehi774 16464911
18. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JN Rasmussen A Chong DA Alter, JAMA 2007 10, 297 2 177 186 10.1001/jama.297.2.177 (Pubitemid 46089734)
19. Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome. AT Yan RT Yan M Tan T Huynh K Soghrati LJ Brunner P DeYoung DH Fitchett A Langer SG Goodman, Am Heart J 2007 154 1108 1115 10.1016/j.ahj.2007.07.040 18035083
20. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). KA Fox OH Dabbous RJ Goldberg KS Pieper KA Eagle F Van de Werf A Avezum SG Goodman MD Flather FA Anderson Jr CB Granger, BMJ 2006 25, 333 7578 1091 1094 10.1136/bmj.38985.646481.55 (Pubitemid 44863647)
21. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JL Anderson CD Adams EM Antman CR Bridges RM Califf DE Casey Jr WE Chavey FM Fesmire JS Hochman TN Levin AM Lincoff ED Peterson P Theroux NK Wenger RS Wright SC Smith Jr AK Jacobs CD Adams JL Anderson EM Antman JL Halperin SA Hunt HM Krumholz FG Kushner BW Lytle R Nishimura JP Ornato RL Page B Riegel, J Am Coll Cardiol 2007 50 1 157 10.1016/j.jacc.2007.02.013 17601538